117 related articles for article (PubMed ID: 34565234)
41. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.
Hwang A; Iskandar AS; Kerr WT; Farrell S; Plaxe SC; Dasanu CA
J Oncol Pharm Pract; 2019 Oct; 25(7):1719-1721. PubMed ID: 30940048
[TBL] [Abstract][Full Text] [Related]
42. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
43. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
44. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia.
Damtie D; Yismaw G; Woldeyohannes D; Anagaw B
BMC Res Notes; 2013 Dec; 6():534. PubMed ID: 24330921
[TBL] [Abstract][Full Text] [Related]
45. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
46. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Ledsky R; McCarthy W; Baxter D; Turiansky GW; Wagner KF; Turianski G
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):746-54. PubMed ID: 7929920
[TBL] [Abstract][Full Text] [Related]
48. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
Nnoruka EN; Chukwuka JC; Anisuiba B
Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
[TBL] [Abstract][Full Text] [Related]
49. CD4
Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
[TBL] [Abstract][Full Text] [Related]
50. [Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience].
Alp E; Bozkurt I; Doğanay M
Mikrobiyol Bul; 2011 Jan; 45(1):125-36. PubMed ID: 21341167
[TBL] [Abstract][Full Text] [Related]
51. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
[TBL] [Abstract][Full Text] [Related]
52. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
Dittmer DP
mBio; 2011; 2(6):e00138-11. PubMed ID: 22045987
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's sarcoma in HIV-infected women and men in Nigeria.
Ibekwe PU; Ogunbiyi OA; Ogun GO; George OA
AIDS Patient Care STDS; 2011 Nov; 25(11):635-7. PubMed ID: 21967494
[TBL] [Abstract][Full Text] [Related]
55. Profile of HIV/AIDS patients in a tertiary hospital in Istanbul, Turkey.
Karaosmanoglu HK; Aydin OA; Nazlican O
HIV Clin Trials; 2011; 12(2):104-8. PubMed ID: 21498153
[TBL] [Abstract][Full Text] [Related]
56. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
[TBL] [Abstract][Full Text] [Related]
57. Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.
Cohen C; Elion R; Ruane P; Shamblaw D; DeJesus E; Rashbaum B; Chuck SL; Yale K; Liu HC; Warren DR; Ramanathan S; Kearney BP
AIDS; 2011 Mar; 25(6):F7-12. PubMed ID: 21412057
[TBL] [Abstract][Full Text] [Related]
58. Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.
Lebari D; Gohil J; Patnaik L; Wasef W
Int J STD AIDS; 2014 Jul; 25(8):607-10. PubMed ID: 24492851
[TBL] [Abstract][Full Text] [Related]
59. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
60. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
